Partner Don Schroeder was quoted in a Law360 article, “Comey Fallout Illuminates Pitfalls Of High-Profile Firings,” covering how President Trump’s firing of FBI Director James Comey relates to high profile dismissals in the private sector, and what to do when high-profile firings trigger a flood of media requests.
Schroeder stated that in-person terminations are “critical” and that “if you conduct yourself with professionalism, it tells the other person that it’s expected they conduct themselves with professionalism.”
He also explained that in situations where a notable dismissal fosters media requests, it’s necessary for a company to have “a well thought out and developed” communications plan with one media point person and the least amount of individuals as possible permitted to speak with the media on the firing.
Schroeder stated that in-person terminations are “critical” and that “if you conduct yourself with professionalism, it tells the other person that it’s expected they conduct themselves with professionalism.”
He also explained that in situations where a notable dismissal fosters media requests, it’s necessary for a company to have “a well thought out and developed” communications plan with one media point person and the least amount of individuals as possible permitted to speak with the media on the firing.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”